Yüklüyor......
Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia
Dysbiosis of the gut microbiota is a contributing factor for obesity-related metabolic diseases such as hyperglycemia and hyperlipidemia. Pharmacotherapy for metabolic diseases involves the modulation of gut microbiota, which is suggested to be a potential therapeutic target. In this study, the modu...
Kaydedildi:
| Yayımlandı: | Front Microbiol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736992/ https://ncbi.nlm.nih.gov/pubmed/31551944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2019.01947 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|